Trial intelligence / Profile preview

Omiganan vs Chlorhexidine for Skin Antisepsis

NCT00608959Phase 3Completed

Sponsor
Cadence Pharmaceuticals, Inc.
Start
May 2008
Primary completion
Jun 2008
Countries
1
01

Overview

A Phase 3 trial of CLS001 topical gel vehicle in catheter infection, sponsored by Cadence Pharmaceuticals, Inc.. Started May 2008; status: completed.

02

Drugs

CLS001 topical gel vehicle
03

Conditions

catheter infection

Beyond the preview

Go deeper on NCT00608959.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00608959.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call